Drugs Made In America Acquisition Corp. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| KARPUS MANAGEMENT, INC. | 05/14/2026 | 2.53 M | $26.52 M | -0.32% | 11.00% |
| FIRST TRUST CAPITAL MANAGEMENT L.P. | 05/14/2026 | 2.24 M | $23.50 M | 0.00% | 9.75% |
| MIZUHO SECURITIES USA LLC | 05/11/2026 | 2.00 M | $20.90 M | 39.52% | 8.70% |
| GLAZER CAPITAL, LLC | 05/14/2026 | 1.68 M | $17.59 M | -7.60% | 7.30% |
| WESTCHESTER CAPITAL MANAGEMENT, LLC | 05/15/2026 | 1.67 M | $17.52 M | 0.00% | 7.26% |
| POLAR ASSET MANAGEMENT PARTNERS INC. | 05/15/2026 | 1.60 M | $16.77 M | 0.00% | 6.96% |
| WOLVERINE ASSET MANAGEMENT LLC | 05/04/2026 | 1.55 M | $16.31 M | 18.83% | 6.76% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 05/15/2026 | 1.32 M | $13.88 M | 100.00% | 5.75% |
| ARISTEIA CAPITAL LLC | 05/15/2026 | 881.72 K | $9.24 M | 0.00% | 3.83% |
| D. E. SHAW & CO., INC. | 05/15/2026 | 690.00 K | $7.25 M | 0.00% | 3.00% |
| HEIGHTS CAPITAL MANAGEMENT, INC | 05/15/2026 | 650.00 K | $6.83 M | 0.00% | 2.83% |
| SHAOLIN CAPITAL MANAGEMENT LLC | 05/15/2026 | 550.00 K | $5.76 M | 172.18% | 2.39% |
| RADCLIFFE CAPITAL MANAGEMENT, L.P. | 05/15/2026 | 546.81 K | $5.74 M | 0.00% | 2.38% |
| LMR PARTNERS LLP | 05/15/2026 | 500.00 K | $5.24 M | 0.00% | 2.17% |
| RIVERNORTH CAPITAL MANAGEMENT, LLC | 05/15/2026 | 418.00 K | $4.38 M | 0.00% | 1.82% |
| WHITEBOX ADVISORS LLC | 05/15/2026 | 400.00 K | $4.19 M | 0.00% | 1.74% |
| METEORA CAPITAL, LLC | 05/15/2026 | 380.30 K | $3.99 M | 100.00% | 1.65% |
| AQR ARBITRAGE LLC | 05/15/2026 | 357.59 K | $3.75 M | -3.67% | 1.55% |
| CLEAR STREET GROUP INC. | 05/15/2026 | 354.05 K | $1.30 M | 8.61% | 1.54% |
| RLH CAPITAL LLC | 04/29/2026 | 316.55 K | $3.32 M | 100.00% | 1.38% |
| HUDSON BAY CAPITAL MANAGEMENT LP | 05/13/2026 | 297.83 K | $3.13 M | -80.79% | 1.29% |
| QUARRY LP | 05/15/2026 | 266.55 K | $2.80 M | 0.00% | 1.16% |
| CONTEXT CAPITAL MANAGEMENT, LLC | 05/07/2026 | 250.00 K | $2.62 M | 0.00% | 1.09% |
| GOVERNORS LANE LP | 05/15/2026 | 250.00 K | $2.62 M | 0.00% | 1.09% |
| TORONTO DOMINION BANK | 05/15/2026 | 203.84 K | $2.14 M | 1.92% | 0.89% |
| 05/15/2026 | 200.00 K | $2.10 M | 0.00% | 0.87% | |
| SONA ASSET MANAGEMENT (US) LLC | 05/15/2026 | 162.80 K | $1.71 M | 100.00% | 0.71% |
| GOLDMAN SACHS GROUP INC | 05/15/2026 | 119.69 K | $1.25 M | 0.00% | 0.52% |
| DLD ASSET MANAGEMENT, LP | 05/13/2026 | 100.56 K | $1.05 M | 0.00% | 0.44% |
| WARBERG ASSET MANAGEMENT LLC | 05/07/2026 | 92.05 K | $966.11 K | 0.00% | 0.40% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 62.27 K | $653.87 K | 36.42% | 0.27% |
| PERISCOPE CAPITAL INC. | 05/14/2026 | 50.00 K | $524.75 K | 0.00% | 0.22% |
| JPMORGAN CHASE & CO | 05/13/2026 | 49.88 K | $523.25 K | 0.12% | 0.22% |
| DAKOTA WEALTH MANAGEMENT | 05/07/2026 | 36.40 K | $381.47 K | 0.00% | 0.16% |
| 05/15/2026 | 31.84 K | $334.16 K | 0.00% | 0.14% | |
| HRT FINANCIAL LP | 05/14/2026 | 27.49 K | $288.00 K | -2.81% | 0.12% |
| BNP PARIBAS ARBITRAGE, SNC | 05/12/2026 | 14.74 K | $154.44 K | 100.00% | 0.06% |
| CITADEL ADVISORS LLC | 05/15/2026 | 10.48 K | $110.00 K | 100.00% | 0.05% |
| MORGAN STANLEY | 05/15/2026 | 58 | $608 | -52.07% | 0.00% |
| J. GOLDMAN & CO LP | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| BULLDOG INVESTORS, LLP | 05/08/2026 | 0 | $0 | -100.00% | 0.00% |
| LOGAN STONE CAPITAL, LLC | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| UBS GROUP AG | 05/05/2026 | 0 | $0 | -100.00% | 0.00% |
| MERCURIA CAPITAL STRATEGIES, LLC | 05/06/2026 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Drugs Made In America Acquisition Corp. institutional Ownership - FAQ's
During the previous two years, 45 institutional investors and hedge funds held shares of Drugs Made In America Acquisition Corp.. The most heavily invested institutionals were:
Context Capital Management, LLC: 0
Karpus Management, Inc.: 2.53 M
First Trust Capital Management L.P.: 2.24 M
GLAZER CAPITAL, LLC: 1.68 M
Westchester Capital Management, LLC: 1.67 M
Polar Asset Management Partners Inc.: 1.6 M
104.97% of Drugs Made In America Acquisition Corp. stock is owned by institutional investors.
Institutional investors have bought a total of 21.54 M shares in the last 24 months. This purchase volume represents approximately $225.55 M in transactions.